Biokin Pharmaceutical Overview
- Year Founded
-
1996
- Status
-
Public
- Employees
-
3,198
- Stock Symbol
-
688506
- Investments
-
1
- Share Price
-
$37.80
- (As of Thursday Closing)
Biokin Pharmaceutical General Information
Description
Sichuan Biokin Pharmaceutical Co Ltd is a chemical drug and biological drug-based company that integrates drug research and development, production and marketing.
Contact Information
Website
www.baili-pharm.comCorporate Office
- Number 1, Building 1, Number 161, Baili Road
- Cross-Strait Science and Technology Industrial Park, Wenjiang District
- Chengdu, Sichuan 610041
- China
Corporate Office
- Number 1, Building 1, Number 161, Baili Road
- Cross-Strait Science and Technology Industrial Park, Wenjiang District
- Chengdu, Sichuan 610041
- China
Biokin Pharmaceutical Stock Performance
As of 19-Nov-2026, Biokin Pharmaceutical’s stock price is $37.80. Its current market cap is $15.6B with 413M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $37.80 | $35.75 | $29.58 - $56.98 | $15.6B | 413M | 1.67M | -$0.45 |
Biokin Pharmaceutical Financials Summary
As of 30-Sep-2026, Biokin Pharmaceutical has a trailing 12-month revenue of $370M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 14,937,402 | 18,725,018 | 10,062,565 | 7,901,208 |
| Revenue | 369,682 | 350,438 | 811,477 | 79,418 |
| EBITDA | (175,598) | (105,559) | 542,709 | (96,866) |
| Net Income | (183,386) | (146,512) | 516,692 | (110,320) |
| Total Assets | 1,995,191 | 1,636,172 | 977,707 | 201,041 |
| Total Debt | 982,353 | 530,854 | 283,357 | 96,007 |
Biokin Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Biokin Pharmaceutical Patents
Biokin Pharmaceutical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026040176-A1 | Composition comprising astragalus membranaceus root extract for soothing, repairing, and moisturizing skin | Pending | 22-Aug-2024 | ||
| AU-2023388731-A1 | Lightening and moisturizing skin care product composition comprising radix astragali and use thereof | Pending | 07-Dec-2022 | ||
| EP-4631495-A1 | Lightening and moisturizing skin care product composition comprising radix astragali and use thereof | Pending | 07-Dec-2022 | ||
| US-20260207469-A1 | Lightening and moisturizing skin care product composition comprising radix astragali and use thereof | Pending | 07-Dec-2022 | ||
| WO-2024120417-A1 | Lightening and moisturizing skin care product composition comprising radix astragali and use thereof | Inactive | 07-Dec-2022 | A61Q19/00 |
Biokin Pharmaceutical Signals
Biokin Pharmaceutical Investments (1)
Biokin Pharmaceutical’s most recent deal was a Early Stage VC with Connexus Therapeutics. The deal was made on 17-Sep-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Connexus Therapeutics | 17-Sep-2026 | Early Stage VC | Drug Discovery |
Biokin Pharmaceutical ESG
Risk Overview
Risk Rating
Updated November, 17, 2026
36.51 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Biokin Pharmaceutical FAQs
-
When was Biokin Pharmaceutical founded?
Biokin Pharmaceutical was founded in 1996.
-
Where is Biokin Pharmaceutical headquartered?
Biokin Pharmaceutical is headquartered in Chengdu, China.
-
What is the size of Biokin Pharmaceutical?
Biokin Pharmaceutical has 3,198 total employees.
-
What industry is Biokin Pharmaceutical in?
Biokin Pharmaceutical’s primary industry is Drug Discovery.
-
Is Biokin Pharmaceutical a private or public company?
Biokin Pharmaceutical is a Public company.
-
What is Biokin Pharmaceutical’s stock symbol?
The ticker symbol for Biokin Pharmaceutical is 688506.
-
What is the current stock price of Biokin Pharmaceutical?
As of 19-Nov-2026 the stock price of Biokin Pharmaceutical is $37.80.
-
What is the current market cap of Biokin Pharmaceutical?
The current market capitalization of Biokin Pharmaceutical is $15.6B.
-
What is Biokin Pharmaceutical’s current revenue?
The trailing twelve month revenue for Biokin Pharmaceutical is $370M.
-
What is Biokin Pharmaceutical’s annual earnings per share (EPS)?
Biokin Pharmaceutical’s EPS for 12 months was -$0.45.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process